Search
for
Sort by
Research 151–180 of 1000+
- Towards the Development of AgoKirs: New Pharmacological Activators to Study Kir2.x Channel and Target Cardiac Disease
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Immunohistochemical, pharmacovigilance, and omics analyses reveal the involvement of ATP-sensitive K+ channel subunits in cancers: role in drug–disease interactions
- Forsythiasides: A review of the pharmacological effects
- Amphiregulin in Fibrotic Diseases and Cancer
- Amphiregulin in Fibrotic Diseases and Cancer
- Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine
- State of the Science Burn Research: Burns in the Elderly
- Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis
- Cardiovascular Risks in Women with Polycystic Ovary Syndrome (PCOS): A Narrative Review
- Female doping: observations from a data lake study in the Hospital District of Helsinki and Uusimaa, Finland
- Targeting integrin pathways: mechanisms and advances in therapy
- New oral anticoagulants and their reversal agents
- Volatile organic compounds: A proinflammatory activator in autoimmune diseases
- Evaluation of noninvasive biospecimens for transcriptome studies
- Risks of Skin, Hair, and Nail Supplements
- Mesenchymal stem cell‐derived exosomes for organ development and cell‐free therapy
- Beta-trace protein in chronic inflammatory demyelinating polyradiculoneuropathy and Guillain-Barré syndrome – clinical utilization and a new insight into pathophysiological mechanisms
- Mechanisms of Impaired Skeletal Muscle Regeneration and Therapeutic Approaches in Aging and Chronic Disease
- Biomedical applications of organoids in genetic diseases
- Selected abstracts from the 47th meeting of the Irish Endocrine Society Sligo, 24th & 25th November 2023
- Skin Manifestations of Rheumatological Diseases
- Toxic and Metabolic Disorders of the Nervous System
- The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
- A Case of Telogen Effluvium as COVID Sequelae
- Cutaneous Reactions to Drugs
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- The Clinical Presentation of Systemic Lupus Erythematosus
- Cytostatics and immunosuppressive drugs
- Low Free Thyroxine (FT4) in critically ill juvenile systemic lupus erythematosus: a diagnostic approach